
1. BMC Infect Dis. 2020 Jul 23;20(1):539. doi: 10.1186/s12879-020-05263-5.

An unusual Staphylococcus saccharolyticus spondylodiscitis post kyphoplasty: a
case report.

Trojani MC(1), Lamy B(2)(3)(4), Ruimy R(2)(3)(4), Amoretti N(5), Risso K(6), Roux
C(7).

Author information: 
(1)Département de Rhumatologie, Université Cote d'Azur, CHU de Nice, Nice,
France. mctroj@hotmail.fr.
(2)Laboratoire de Bactériologie, Hôpital L'archet 2, CHU de Nice, Nice, France.
(3)INSERM U1065, Centre Méditerranéen de Médecine Moléculaire, Equipe 6, Nice,
France.
(4)Faculté de Médecine, Université Côte d'Azur, Nice, France.
(5)Département de Radiologie, Université Cote d'Azur, CHU de Nice, Nice, France.
(6)Service d'infectiologie, Université Nice Côte d'Azur, CHU de Nice, Nice,
France.
(7)Département de Rhumatologie, Université Cote d'Azur, LAHMESS EA6309, CNRS, iBV
UMR 7277, CHU de Nice, Nice, France.

BACKGROUND: Staphylococcus saccharolyticus is a rarely encountered
coagulase-negative, which grows slowly and its strictly anaerobic staphylococcus 
from the skin. It is usually considered a contaminant, but some rare reports have
described deep-seated infections. Virulence factors remain poorly known,
although, genomic analysis highlights pathogenic potential.
CASE PRESENTATION: We report a case of Staphylococcus saccharolyticus
spondylodiscitis that followed kyphoplasty, a procedure associated with a low
rate but possible severe infectious complication (0.46%), and have reviewed the
literature. This case specifically stresses the risk of healthcare-associated S. 
saccharolyticus infection in high-risk patients (those with a history of
alcoholism and heavy smoking).
CONCLUSION: S. saccharolyticus infection is difficult to diagnose due to
microbiological characteristics of this bacterium; it requires timely treatment, 
and improved infection control procedure should be encouraged for high-risk
patients.

DOI: 10.1186/s12879-020-05263-5 
PMCID: PMC7379344
PMID: 32703263  [Indexed for MEDLINE]

